Btech Investor provides
consulting on the biotechnology industry to the financial and
biotechnology communities and publishes the Btech Investor Reports and
Btech Investor News.
Btech Investor Reports provide in-depth analysis of
the biotechnology industry and consist of company reports on the leaders
of the biotechnology industry and emerging scientific trends in the
biotechnology industry.
Btech News, published several times a week,
highlights selected events in the life sciences sector that the Btech
Investor team believes are particularly relevant to biotechnology
investors. Consulting services include expert analysis and critical
appraisal of biotechnology and pharmaceutical products and technologies,
market analysis, and scientific and financial due diligence.
RETURN
TO INDEX
BTECH NEWS, published by Btech Investor, Inc., highlights selected events in
the life sciences sector that the Btech Investor team believes are particularly relevant to biotechnology investors. The Btech Investor team
combines scientific, clinical, and business experience to perform comprehensive analysis of the biotechnology industry and to identify future
industry leaders.
BTECH INVESTOR REPORTS
The Btech Investor Reports provide in-depth analysis of the biotechnology
industry. Recent companies profiled include Vertex, EntreMed, Élan, IDEC
Pharmaceuticals, Myriad Genetics, and Abgenix. Recent sector reports include
nucleic acid therapeutics, Alzheimer disease, inhaled insulin, recombinant
proteins, gene therapy, monoclonal antibodies, neurodegenerative diseases,
stem cells, trends in oncology, genomics based drug discovery, and biotech
trends.
DISCLAIMER
Btech Investor aims to provide reliable, insightful analysis on the biotechnology industry. However, this information is provided "as is" and no
representations or warranties, either express or implied of completeness,
accuracy, or of any other nature are made with respect to this information.
This information is neither an offer to sell nor a solicitation to buy the
securities of any company. This email contains forward-looking statements,
which involve risks and uncertainties which may not be listed. The biotechnology industry is an emerging industry and the securities of the
companies mentioned in this report have a very high degree of risk and volatility. For this reason, this information is supplied on the condition
that the reader will make his or her own determination as to its suitability
for any purpose prior to any use of the information contained within this
email. The employees and officers of Btech Investor may hold positions in
some or all of the stocks discussed in this report.
© Copyright 2002, Btech Investor, Inc.
